Basic clinical and demographic information about the patients included in the study
| MS | AQP4-ab NMOSD | MOG-ab NMOSD | ab-negative NMOSD/MS-like syndromes | |
|---|---|---|---|---|
| Number of patients | 44 | 31 | 21 | 16 |
| Female to male | 31:13 | 26:5 | 11:10 | 11:5 |
| Mean age at onset (range) | 34.6 (17–57) | 42.5 (13–82) | 24.3 (2–50) | 37.2 (11–55) |
| Mean age at MRI (range) | 38.6 (18–58) | 46.4 (22–82) | 27.5 (2–50) | 42.1 (15–61) |
| Median follow-up in months (range) | 48 (0–188) | 47 (0–128) | 1 (0–265) | 53 (0–131) |
| Mean EDSS (range) | 2.7 (0–7) | 3.7 (1–9) | 4.9 (1–8) | 2.9 (0–6) |
EDSS, expanded disability status scale; MOG, myelin oligodendrocyte glycoprotein; MS, multiple sclerosis; NMOSD, neuromyelitis optica spectrum disorders.